z-logo
open-access-imgOpen Access
New Horizons in orthostatic hypotension: Table 1.
Author(s) -
James Frith,
Steve W. Parry
Publication year - 2016
Publication title -
age and ageing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.014
H-Index - 143
eISSN - 1468-2834
pISSN - 0002-0729
DOI - 10.1093/ageing/afw211
Subject(s) - midodrine , fludrocortisone , medicine , orthostatic vital signs , intensive care medicine , narrative review , atomoxetine , blood pressure , psychiatry , attention deficit hyperactivity disorder , hydrocortisone , methylphenidate
orthostatic hypotension (OH) is a common disabling condition associated with increased morbidity and mortality. Much of the evidence available is derived from younger populations with chronic neurological disease leading to uncertainty for the diagnosis and management of older people.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom